Litcius/Paper detail

Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients

Anna P. Sokolenko, Tatiana N. Sokolova, E. Imyanitov, Elena V. Preobrazhenskaya, Aglaya G. Iyevleva, Svetlana N. Aleksakhina, Alexandr A. Romanko, Alexandr A. Bessonov, Tatiana V. Gorodnova, Elena I. Anisimova, E. Savonevich, Ilya V. Bizin, Ilya A. Stepanov, Petr Krivorotko, И. В. Берлев, А. М. Belyaev, Alexandr V. Togo, Evgeny N. Imyanitov

2020Breast Cancer Research and Treatment38 citationsDOI

Topics & Concepts

Founder effectOvarian cancerBreast cancerLoss of heterozygosityMedicineCancerBRCA2 ProteinMutationAlleleOncologyInternal medicineGeneticsBiologyGermline mutationHaplotypeGeneBRCA gene mutations in cancerPARP inhibition in cancer therapyOvarian cancer diagnosis and treatment